Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review. | Brachytherapy | 2017 | 28110898 | PubTator, text mining | PubMed |
| Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas. | Sci Rep | 2017 | 28102292 | PubTator, text mining | PubMed |
| Effects of cranberry extracts on gene expression in THP-1 cells. | Food Sci Nutr | 2017 | 28070326 | PubTator, text mining | PubMed |
| Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery. | Oncotarget | 2017 | 28061466 | PubTator, text mining | PubMed |
| Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer's Disease. | PLoS One | 2017 | 28060825 | PubTator, text mining | PubMed |
| Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without Carboplatin. | Clin Genitourin Cancer | 2017 | 28038931 | PubTator, text mining | PubMed |
| Epigenetic therapy in urologic cancers: an update on clinical trials. | Oncotarget | 2017 | 28036257 | PubTator, text mining | PubMed |
| Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cells. | Oncotarget | 2017 | 28031533 | PubTator, text mining | PubMed |
| Purification of a Human Prostate Specific Antigen. | J Urol | 2017 | 28012750 | PubTator, text mining | PubMed |
| Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer. | Oncotarget | 2017 | 28009986 | PubTator, text mining | PubMed |
| Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer. | Oncotarget | 2017 | 27903962 | PubTator, text mining | PubMed |
| Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. | Oncotarget | 2017 | 27901495 | PubTator, text mining | PubMed |
| Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results. | Acta Neurochir (Wien) | 2017 | 27878374 | PubTator, text mining | PubMed |
| The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats. | Toxicol Lett | 2017 | 27866977 | PubTator, text mining | PubMed |
| Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial. | Clin Cancer Res | 2017 | 27836866 | PubTator, text mining | PubMed |
| Is there a role for therapeutic cancer vaccines in the age of checkpoint inhibitors? | Hum Vaccin Immunother | 2017 | 27808593 | PubTator, text mining | PubMed |
| Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles. | Oncotarget | 2017 | 27741508 | PubTator, text mining | PubMed |
| Early use of chemotherapy in metastatic prostate cancer. | Cancer Treat Rev | 2017 | 27720577 | PubTator, text mining | PubMed |
| Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell Clusters. | Clin Cancer Res | 2017 | 27702818 | PubTator, text mining | PubMed |
| Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte Isolation. | Clin Cancer Res | 2017 | 27401243 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=59